Bronchodilator reversibility (BDR) - should we measure it in adults with symptoms but without obstructed spirometry?

M. Bennett (Manchester, United Kingdom), S. Drake (Manchester, United Kingdom), L. Healy (Manchester, United Kingdom), R. Tudge (Manchester, United Kingdom), L. Lowe (Manchester, United Kingdom), L. Willmore (Manchester, United Kingdom), L. Willmore (Manchester, United Kingdom), J. Mitchell (Manchester, United Kingdom), G. Kerry (Manchester, United Kingdom), C. Murray (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Simpson (Manchester, United Kingdom)

Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Session: Primary care diagnosis and multimorbidities
Session type: E-poster
Number: 3626

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bennett (Manchester, United Kingdom), S. Drake (Manchester, United Kingdom), L. Healy (Manchester, United Kingdom), R. Tudge (Manchester, United Kingdom), L. Lowe (Manchester, United Kingdom), L. Willmore (Manchester, United Kingdom), L. Willmore (Manchester, United Kingdom), J. Mitchell (Manchester, United Kingdom), G. Kerry (Manchester, United Kingdom), C. Murray (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Simpson (Manchester, United Kingdom). Bronchodilator reversibility (BDR) - should we measure it in adults with symptoms but without obstructed spirometry?. 3626

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Do obese asthmatics have a worse bronchodilator response?
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Concordance between oscillometric and spirometric lung function measures in bronchodilator response test for the detection of airway obstruction
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016

Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Response to bronchodilators in school children with asthma and normal FEV1
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016

How to interpret bronchodilator response (BDR) in children?
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry?
Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children
Year: 2018



Should reversibility be assessed in all asthmatic children with normal spirometry?
Source: Eur Respir J, 52 (2) 1800373; 10.1183/13993003.00373-2018
Year: 2018



Irreversible airways obstruction on spirometry, does it equate to a diagnosis of COPD?
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012

Bronchodilator reversibility - differences between asthma and COPD
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019


Airway resistances deteriorate following spirometry in asthma and COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

The assessment of reversibility airway obstruction in children 3-4 years with bronchial asthma by impulse oscillometry
Source: Eur Respir J 2002; 20: Suppl. 38, 172s
Year: 2002

Does measuring pre or post bronchodilator FEV1 influence the level of asthma control in patients with controlled or partially controlled asthma as measured by GINA scale?
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Assessment of bronchodilator reversibility in patients with bronchiectasis (BE)
Source: Eur Respir J 2001; 18: Suppl. 33, 134s
Year: 2001

Limitations of forced spirometry in the detection of bronchodilator response in asthmatic children
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015

Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction?
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008



Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Five FEV1 adjustment methods for grading airway obstruction severity in USA Caucasian patients
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015


Small airway dysfunction by impulse oscillometry system (IOS) in asthma. Relationship with spirometry, bronchodilator response and disease control
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012

Bronchodilator reversibility testing in COPD: which parameter?
Source: Eur Respir J 2006; 28: Suppl. 50, 202s
Year: 2006